Anil Badhwar, MD
Allergy & Immunology · Searcy, ARNPI 1992764260
Payments from drug & device makers
Across 163 payments — averaging $3061.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$289K
- Novartis$98K
- Astrazeneca AB$73K
- Sanofi US Services Inc.$28K
- Chiesi USA, Inc.$6K
- Alk-abello, Inc$1K
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $288,519 |
| Novartis | 15 | $97,596 |
| Astrazeneca AB | 4 | $72,986 |
| Sanofi US Services Inc. | 11 | $27,560 |
| Chiesi USA, Inc. | 2 | $6,494 |
| Alk-abello, Inc | 1 | $1,240 |
| GSK | 37 | $1,065 |
| Amgen | 8 | $836 |
| Regeneron Healthcare Solutions, Inc. | 3 | $349 |
| Paratek Pharmaceuticals, Inc. | 3 | $301 |
| Blueprint Medicines Corporation | 6 | $271 |
| Phathom Pharmaceuticals, Inc. | 2 | $198 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $169 |
| Abbott | 1 | $158 |
| Phadia US Inc. | 1 | $150 |
| UCB, Inc. | 1 | $147 |
| Sanofi | 3 | $145 |
| Genentech USA, Inc. | 3 | $140 |
| Gilead | 1 | $125 |
| Merck | 1 | $100 |
| Grifols USA, LLC | 2 | $95 |
| Boehringer Ingelheim | 2 | $95 |
| Pharming Healthcare, Inc. | 1 | $91 |
| Johnson & Johnson | 1 | $64 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| CSL Behring | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$499,040 in reported general payments places this provider in the 95th percentile of 26 allergy & immunology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Searcy
- Karl SitzLittle Rock$1.9M
- Blake ScheerLittle Rock$81K
- Jim IngramLittle Rock$62K
- Jenny CampbellRogers$13K
- Curtis HedbergRogers$11K
- Stacy GriffinLittle Rock$10K
- Adesua WejinyaRogers$10K
- Ashley StonerLittle Rock$7K
- Kim JacksonLittle Rock$6K
- Aubrey ZieglerFort Smith$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.